Oruka Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $10.3M | $8.7M |
| FY2018 | — | $6.0M | $6.6M |
| FY2019 | — | $7.6M | $8.4M |
| FY2020 | — | $46.5M | $49.1M |
| FY2021 | — | $51.0M | $53.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $10.3M | $8.7M |
| FY2018 | — | $6.0M | $6.6M |
| FY2019 | — | $7.6M | $8.4M |
| FY2020 | — | $46.5M | $49.1M |
| FY2021 | — | $51.0M | $53.4M |